Ginkgo Bioworks Holdings, Inc.
NYSE:DNA
6.46 (USD) • At close March 13, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2001 | |
|---|---|---|---|---|---|---|---|
| Assets: | |||||||
| Current Assets: | |||||||
| Cash & Cash Equivalents
| 561.572 | 944.073 | 1,315.792 | 1,550.004 | 380.801 | 495.287 | 1,315.792 |
| Short Term Investments
| 0 | -0.654 | 0 | 0 | 0 | 0 | 0 |
| Cash and Short Term Investments
| 561.572 | 944.073 | 1,315.792 | 1,550.004 | 380.801 | 495.287 | 1,315.792 |
| Net Receivables
| 21.857 | 31.738 | 82.465 | 149.899 | 21.906 | 7.678 | 80.907 |
| Inventory
| 0 | 0.046 | 4.364 | 3.362 | 2.736 | 0 | 4.364 |
| Other Current Assets
| 19.315 | 25.892 | 47.458 | 19.78 | 21.099 | 8.96 | 49.016 |
| Total Current Assets
| 602.744 | 1,001.749 | 1,450.079 | 1,723.045 | 426.542 | 511.925 | 1,450.079 |
| Non-Current Assets: | |||||||
| Property, Plant & Equipment, Net
| 598.155 | 397.224 | 715.535 | 145.77 | 121.435 | 63.132 | 715.535 |
| Goodwill
| 0 | 49.238 | 60.21 | 21.312 | 1.857 | 1.857 | 60.21 |
| Intangible Assets
| 72.51 | 82.741 | 111.041 | 21.642 | 3.294 | 3.843 | 111.041 |
| Goodwill and Intangible Assets
| 72.51 | 131.979 | 171.251 | 42.954 | 5.151 | 5.7 | 171.251 |
| Long Term Investments
| 48.704 | 78.565 | 113.731 | 115.231 | 103.124 | 107.253 | 0 |
| Tax Assets
| 0 | 0 | 0 | 0 | 13.298 | 0 | 0 |
| Other Non-Current Assets
| 55.336 | 55.825 | 88.725 | 43.99 | 5.603 | 9.308 | 202.456 |
| Total Non-Current Assets
| 774.705 | 663.593 | 1,089.242 | 347.945 | 248.611 | 185.393 | 1,089.242 |
| Total Assets
| 1,377.449 | 1,665.342 | 2,539.321 | 2,070.99 | 675.153 | 697.318 | 2,539.321 |
| Liabilities & Equity: | |||||||
| Current Liabilities: | |||||||
| Account Payables
| 14.169 | 9.323 | 10.451 | 8.189 | 13.893 | 2.439 | 10.451 |
| Short Term Debt
| 0 | 19.933 | 29.332 | 0.747 | 0.485 | 0.598 | 0 |
| Tax Payables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue
| 27.71 | 48.495 | 47.817 | 33.24 | 28.823 | 0 | 47.817 |
| Other Current Liabilities
| 65.387 | 86.109 | 85.362 | 92.585 | 30.02 | 37.037 | 114.694 |
| Total Current Liabilities
| 107.266 | 163.86 | 172.962 | 134.761 | 73.221 | 40.074 | 172.962 |
| Non-Current Liabilities: | |||||||
| Long Term Debt
| 438.766 | 221.835 | 413.256 | 22.283 | -108.49 | 16.767 | 413.256 |
| Deferred Revenue Non-Current
| 0 | 158.062 | 174.767 | 155.991 | 99.652 | 0 | 174.767 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 154.584 | 12.678 | 0 | 0 |
| Other Non-Current Liabilities
| 115.359 | 24.433 | 42.059 | 190.576 | -9.646 | 138.624 | 42.059 |
| Total Non-Current Liabilities
| 554.125 | 404.33 | 630.082 | 368.85 | 131.88 | 155.391 | 630.082 |
| Total Liabilities
| 661.391 | 568.19 | 803.044 | 503.611 | 205.101 | 195.465 | 803.044 |
| Equity: | |||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0.177 | 0 |
| Common Stock
| 0.005 | 0.199 | 0.19 | 0.161 | 0.129 | 0.079 | 0.19 |
| Retained Earnings
| -5,837.557 | -5,290.528 | -4,397.659 | -2,297.925 | -467.878 | -341.269 | -4,397.659 |
| Accumulated Other Comprehensive Income/Loss
| -1.806 | 1.484 | -2.632 | -1.715 | -0 | 0 | 0 |
| Other Total Stockholders Equity
| 6,555.416 | 6,385.997 | 6,136.378 | 3,804.844 | 929.125 | 834.076 | 6,133.746 |
| Total Shareholders Equity
| 716.058 | 1,097.152 | 1,736.277 | 1,505.365 | 461.376 | 493.063 | 1,736.277 |
| Total Equity
| 716.058 | 1,097.152 | 1,736.277 | 1,567.379 | 470.052 | 501.853 | 1,736.277 |
| Total Liabilities & Shareholders Equity
| 1,377.449 | 1,665.342 | 2,539.321 | 2,070.99 | 675.153 | 697.318 | 2,539.321 |